Ruhnke, L., Röllig, C., Herold, S., Sauer, T., Brandts, C. H., Steffen, B., Schäfer-Eckart, K., Krause, S. W., Hänel, M., Reichle, A., Scholl, S., Neubauer, A., Mikesch, J.-H., Schetelig, J., Stölzel, F., Kramer, M., Haake, A., Frimmel, J., Krämer, A., Schlenk, R., Platzbecker, U., Serve, H., Baldus, C. D., Müller-Tidow, C., Aust, D., Bornhäuser, M., Ehninger, G. and Thiede, C. (2023) “Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i&gt;- ITD mutations: results of the SAL MIDOKIT trial”, Haematologica. Pavia, Italy, 108(9), pp. 2520-2525. doi: 10.3324/haematol.2022.281636.